Novanta (NASDAQ:NOVT) Announces Earnings Results

Novanta (NASDAQ:NOVT) announced its earnings results on Wednesday. The technology company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.83 by $0.06, FiscalAI reports. Novanta had a return on equity of 11.96% and a net margin of 6.00%.The company had revenue of $265.81 million for the quarter, compared to analysts’ expectations of $262.30 million. During the same quarter in the prior year, the business earned $0.76 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. Novanta updated its FY 2026 guidance to 3.680-3.740 EPS and its Q3 2026 guidance to 0.950-1.000 EPS.

Novanta Trading Up 3.6%

NASDAQ NOVT traded up $5.96 during trading hours on Friday, hitting $169.28. The company’s stock had a trading volume of 159,444 shares, compared to its average volume of 470,080. Novanta has a twelve month low of $98.27 and a twelve month high of $176.38. The firm has a market capitalization of $6.39 billion, a P/E ratio of 108.51 and a beta of 1.68. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15. The stock has a fifty day moving average of $153.93 and a 200 day moving average of $141.42.

Wall Street Analyst Weigh In

A number of brokerages have commented on NOVT. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Robert W. Baird set a $194.00 price target on shares of Novanta in a research note on Friday. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Novanta presently has a consensus rating of “Hold” and a consensus target price of $194.00.

Insider Activity at Novanta

In other news, CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total value of $1,047,345.00. Following the transaction, the chief executive officer owned 29,761 shares of the company’s stock, valued at $4,795,389.93. This represents a 17.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.

Institutional Investors Weigh In On Novanta

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Danske Bank A S acquired a new position in shares of Novanta during the 3rd quarter worth about $40,000. Van ECK Associates Corp raised its position in shares of Novanta by 17.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock valued at $163,000 after acquiring an additional 239 shares during the period. O Shaughnessy Asset Management LLC bought a new position in Novanta during the 4th quarter worth approximately $219,000. Boothbay Fund Management LLC bought a new position in Novanta during the 3rd quarter worth approximately $261,000. Finally, EntryPoint Capital LLC acquired a new position in Novanta during the fourth quarter valued at approximately $261,000. Institutional investors own 98.35% of the company’s stock.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.